Tilray Brands Inc

TLRY

Company Profile

  • Business description

    Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

  • Contact

    265 Talbot Street West
    LeamingtonONN8H 5L4
    CAN

    T: +1 844 845-7291

    E: [email protected]

    https://www.tilray.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 May 2025

    Employees

    2,650

Tilray Brands Inc News & Analysis

stocks

10 of the cheapest US stocks of 2022

One silver lining of the bear market is half the US stocks followed by Morningstar analysts are now undervalued.
stocks

Weed flies high

Cannabis stocks rally massively on senate majority leader Schumer’s push for major legislation.
stocks

Possible Biden win may spur cannabis industry growth

Companies with US exposure are better positioned to benefit from easing prohibition, writes Kristoffer Inton.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,316.7098.30-1.17%
CAC 407,274.4819.89-0.27%
DAX 4019,884.7585.11-0.43%
Dow JONES (US)42,840.26498.021.18%
FTSE 1008,084.6120.71-0.26%
HKSE19,720.7031.81-0.16%
NASDAQ19,572.60199.831.03%
Nikkei 22538,701.90111.68-0.29%
NZX 50 Index12,878.5825.53-0.20%
S&P 5005,930.8563.771.09%
S&P/ASX 2008,067.00101.20-1.24%
SSE Composite Index3,368.071.96-0.06%

Market Movers